Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy.
Authors
Ho, Kean FMarchant, Thomas E
Moore, Christopher J
Webster, Gareth J
Rowbottom, Carl G
Pennington, Hazel
Lee, Lip W
Yap, Beng K
Sykes, Andrew J
Slevin, Nicholas J
Affiliation
Academic Radiation Oncology, The Christie NHS Foundation Trust, Manchester, UK. hokeanfatt@hotmail.comIssue Date
2012-03-01
Metadata
Show full item recordAbstract
Parotid-sparing head-and-neck intensity-modulated radiotherapy (IMRT) can reduce long-term xerostomia. However, patients frequently experience weight loss and tumor shrinkage during treatment. We evaluate the use of kilovoltage (kV) cone beam computed tomography (CBCT) for dose monitoring and examine if the dosimetric impact of such changes on the parotid and critical neural structures warrants replanning during treatment.Citation
Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy. 2012, 82 (3):e375-82 Int J Radiat Oncol Biol PhysJournal
International Journal of Radiation Oncology, Biology, PhysicsDOI
10.1016/j.ijrobp.2011.07.004PubMed ID
22197229Type
ArticleLanguage
enISSN
1879-355Xae974a485f413a2113503eed53cd6c53
10.1016/j.ijrobp.2011.07.004